Status:
TERMINATED
The Influence of Gonadal Hormone Suppression on Adipocyte Lineage and the Microbiome
Lead Sponsor:
University of Colorado, Denver
Conditions:
Adipose Tissue
Microbiome
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
This research study plans to learn more about the role of female sex hormones on adipose tissue (or fat) and the gut microbiome (or the organisms that are in your digestive tract). The rationale for t...
Eligibility Criteria
Inclusion
- Enrollment into the parent protocol (COMIRB 16-1479 - The impact of estrogen status on the biological function of brown adipose tissue in women measured using quantitative PET/CT; PI - Edward Melanson, PhD)
- Participation in GnRHag intervention
Exclusion
- Known allergy to lidocaine or other numbing medication
- Uncontrolled bleeding disorder or inability to withhold aspirin/NSAIDs or other blood thinning medications for 7 days prior to biopsy procedure.
Key Trial Info
Start Date :
January 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2019
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03396978
Start Date
January 11 2018
End Date
December 18 2019
Last Update
August 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States, 80045